Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis

Figure 3 Kaplan-Meier survival analysis of patients after transjugular intrahepatic portosystemic shunt placement. A: Subgroup analysis with patients having a model for end-stage liver disease score (MELD) < 10: Significant difference in overall survival relating to indication [refractory ascites (RA) vs variceal bleeding (VB) group, log rank test P = 0.031]; B: Subgroup analysis with patients having a MELD score > 10: No significant difference in overall survival relating to indication (RA vs VB group, log rank test P = 0.274); C: Subgroup analysis with patients with CHILD B or C cirrhosis: Significant difference in overall survival relating to indication (RA vs VB group, log rank test P = 0.021); D: Subgroup analysis with patients age > 65 years: Significant difference in overall survival relating to indication (RA vs VB group, log rank test P = 0.021); E: Subgroup analysis with stent occlusion at first control: No significant difference in overall survival relating to indication (RA vs VB group, log rank test P = 0.289).